|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
EP0958305B1
(en)
|
1996-07-05 |
2008-06-04 |
Cancer Research Technology Limited |
Inhibitions of the interaction between p53 and mdm2
|
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
|
JP3786832B2
(ja)
|
1998-01-07 |
2006-06-14 |
デビオ ルシェルシュ ファルマシュティーク ソシエテ アノニム |
分解性のヘテロ二官能性ポリ（エチレングリコール）アクリレート及びそれから誘導されるゲル及び複合体
|
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
|
BR0001870B1
(pt)
|
2000-05-29 |
2014-02-25 |
|
Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas
|
|
EP1997828B1
(en)
|
2003-11-05 |
2017-10-04 |
Dana-Farber Cancer Institute, Inc. |
Stabilized alpha helical peptides from BCL-2 and uses thereof
|
|
US8937154B2
(en)
|
2006-10-05 |
2015-01-20 |
New York Blood Center, Inc. |
Stabilized therapeutic small helical antiviral peptides
|
|
EP2952522B1
(en)
|
2007-01-31 |
2019-10-30 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
|
ES2398310T3
(es)
|
2007-02-23 |
2013-03-15 |
Aileron Therapeutics, Inc. |
Péptidos macrocíclicos unidos a triazol
|
|
AU2008232709C1
(en)
|
2007-03-28 |
2015-01-15 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
|
JP5783721B2
(ja)
|
2007-09-26 |
2015-09-24 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
Ｂｃｌ−２ファミリーポリペプチドを調節する方法及び組成物
|
|
GB0804701D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
|
CA2725227A1
(en)
|
2008-05-06 |
2009-11-12 |
Asim Kumar Debnath |
Antiviral cell penetrating peptides
|
|
WO2010011313A2
(en)
|
2008-07-23 |
2010-01-28 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
|
US8586707B2
(en)
|
2008-09-16 |
2013-11-19 |
The Research Foundation Of State University Of New York |
Stapled peptides and method of synthesis
|
|
ES2666458T3
(es)
|
2008-09-22 |
2018-05-04 |
Aileron Therapeutics, Inc. |
Macrociclos peptidomiméticos
|
|
EP2352507A4
(en)
|
2008-11-24 |
2012-04-25 |
Aileron Therapeutics Inc |
PEPTIDOMIMETIC MACROCYCLES WITH IMPROVED PROPERTIES
|
|
US9079970B2
(en)
|
2008-12-09 |
2015-07-14 |
Dana Farber Cancer Institute, Inc. |
Methods and compositions for specific modulation of MCL-1
|
|
WO2010083347A2
(en)
|
2009-01-14 |
2010-07-22 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
CA2761568C
(en)
|
2009-06-18 |
2020-10-13 |
Dana-Farber Cancer Institute, Inc. |
Structured viral peptide compositions and methods of use
|
|
JP2012532929A
(ja)
*
|
2009-07-13 |
2012-12-20 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
二機能性のステープリングされたポリペプチドおよびそれらの使用
|
|
HUE041436T2
(hu)
|
2009-12-10 |
2019-05-28 |
Univ Minnesota |
Tal-effektor-közvetített DNS-módosítás
|
|
US9227995B2
(en)
|
2010-04-23 |
2016-01-05 |
Øyvind Jacobsen |
Peptides
|
|
US9297017B2
(en)
|
2010-06-08 |
2016-03-29 |
University Of Washington |
Methods and compositions for targeted protein degradation
|
|
SG186389A1
(en)
|
2010-06-30 |
2013-01-30 |
Univ Brandeis |
Small-molecule-targeted protein degradation
|
|
JP2013532172A
(ja)
|
2010-07-09 |
2013-08-15 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
安定化したインスリン分泌促進ペプチド及び使用方法
|
|
KR20170058446A
(ko)
|
2010-08-13 |
2017-05-26 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티도미메틱 거대고리
|
|
WO2012040459A2
(en)
|
2010-09-22 |
2012-03-29 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
|
JP2014502152A
(ja)
|
2010-11-12 |
2014-01-30 |
ダナ ファーバー キャンサー インスティテュート，インコーポレイテッド |
癌の治療及び診断
|
|
AU2011338615B2
(en)
|
2010-12-07 |
2017-07-27 |
Yale University |
Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
|
|
US8762795B2
(en)
|
2010-12-17 |
2014-06-24 |
Microsoft Corporation |
Alerting recipients to errors occurring when accessing external services
|
|
WO2013036208A1
(en)
|
2011-09-09 |
2013-03-14 |
Agency For Science, Technology And Research |
P53 activating peptides
|
|
AR088392A1
(es)
|
2011-10-18 |
2014-05-28 |
Aileron Therapeutics Inc |
Macrociclos peptidomimeticos
|
|
US9346868B2
(en)
|
2011-11-14 |
2016-05-24 |
Carlos Witte-Hoffmann |
BLID; a novel protein domain for interaction with the Bcl-2 family of proteins. Applications in oncology
|
|
US9408885B2
(en)
|
2011-12-01 |
2016-08-09 |
Vib Vzw |
Combinations of therapeutic agents for treating melanoma
|
|
WO2013116829A1
(en)
|
2012-02-03 |
2013-08-08 |
The Trustees Of Princeton University |
Novel engineered potent cytotoxic stapled bh3 peptides
|
|
CA2862038C
(en)
|
2012-02-15 |
2021-05-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US9556229B2
(en)
|
2012-05-18 |
2017-01-31 |
The Regents Of The University Of California |
Modification of peptides using a bis(thioether)arylbridge approach
|
|
ES2874525T3
(es)
|
2012-09-26 |
2021-11-05 |
Harvard College |
Péptidos grapados bloqueados con prolina y usos de los mismos
|
|
WO2014053879A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
WO2014053881A1
(en)
|
2012-10-04 |
2014-04-10 |
Centre National De La Recherche Scientifique |
Cell penetrating peptides for intracellular delivery of molecules
|
|
KR101616603B1
(ko)
|
2012-10-11 |
2016-04-28 |
서울대학교산학협력단 |
메틸 데그론 펩타이드 및 이를 이용한 단백질 수명 조절 방법
|
|
AU2013359262C1
(en)
|
2012-12-12 |
2021-05-13 |
Massachusetts Institute Of Technology |
CRISPR-Cas component systems, methods and compositions for sequence manipulation
|
|
CN104981249B
(zh)
|
2012-12-18 |
2018-06-19 |
英国卫生部 |
抗微生物化合物、它们的合成及其应用
|
|
US9493510B2
(en)
|
2013-01-10 |
2016-11-15 |
Noliva Therapeutics Llc |
Peptidomimetic compounds
|
|
US9115184B2
(en)
|
2013-03-01 |
2015-08-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Light-inducible system for regulating protein stability
|
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
|
US10017551B2
(en)
|
2013-03-15 |
2018-07-10 |
The Regents Of The University Of California |
Peptides having reduced toxicity that stimulate cholesterol efflux
|
|
CN106103472A
(zh)
|
2013-10-01 |
2016-11-09 |
哈佛大学的校长及成员们 |
稳定化的多肽及其用途
|
|
AU2014346559B2
(en)
|
2013-11-07 |
2020-07-09 |
Editas Medicine,Inc. |
CRISPR-related methods and compositions with governing gRNAs
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
US10682388B2
(en)
|
2014-01-15 |
2020-06-16 |
The Board Of Regents Of The University Of Texas System |
Targeting of PELP1 in cancer therapy
|
|
US10040780B2
(en)
|
2014-03-03 |
2018-08-07 |
The Regents Of The University Of California |
Mcl-1 antagonists
|
|
AU2015259191B2
(en)
|
2014-05-13 |
2019-03-21 |
Sangamo Therapeutics, Inc. |
Methods and compositions for prevention or treatment of a disease
|
|
CN114805527A
(zh)
|
2014-05-21 |
2022-07-29 |
哈佛大学的校长及成员们 |
Ras抑制肽和其用途
|
|
WO2016019144A2
(en)
|
2014-07-30 |
2016-02-04 |
Sangamo Biosciences, Inc. |
Gene correction of scid-related genes in hematopoietic stem and progenitor cells
|
|
US9816080B2
(en)
|
2014-10-31 |
2017-11-14 |
President And Fellows Of Harvard College |
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
|
|
CN112877327B
(zh)
|
2014-12-18 |
2024-11-22 |
综合基因技术公司 |
基于crispr的组合物和使用方法
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
JP6815318B2
(ja)
*
|
2014-12-23 |
2021-01-20 |
ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド |
二官能性分子によって標的化タンパク質分解を誘導する方法
|
|
EP3250691B9
(en)
|
2015-01-28 |
2023-08-02 |
Caribou Biosciences, Inc. |
Crispr hybrid dna/rna polynucleotides and methods of use
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
WO2017004591A2
(en)
|
2015-07-02 |
2017-01-05 |
Dana-Farber Cancer Institute, Inc. |
Stabilized anti-microbial peptides
|
|
EP3337476A4
(en)
*
|
2015-08-19 |
2019-09-04 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
EP3341008B1
(en)
*
|
2015-08-28 |
2026-04-15 |
Dana-Farber Cancer Institute, Inc. |
Peptides binding to bfl-1
|
|
WO2017040323A2
(en)
*
|
2015-08-28 |
2017-03-09 |
Dana-Farber Cancer Institute, Inc. |
Stabilized peptides for covalent binding to target protein
|
|
JP7105696B2
(ja)
|
2016-02-29 |
2022-07-25 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド
|
|
AU2017238390A1
(en)
|
2016-03-23 |
2018-09-27 |
Dana-Farber Cancer Institute, Inc. |
Compositions, assays, and methods for targeting HDM2 and HDMX to reverse the inhibition of p53 in pediatric cancers
|
|
EP3458101B1
(en)
*
|
2016-05-20 |
2020-12-30 |
H. Hoffnabb-La Roche Ag |
Protac antibody conjugates and methods of use
|